VIE/AFX (VIE/AFX)

Vienna Stock Exchange: VIE/AFX · EUR

€35.3

+0.02 (+0.1%)· Recorded snapshot

Market cap	3B
Revenue (ttm)	2.2B
Net income (ttm)	121.5M
EPS (ttm)	€1.39
P/E (trailing)	25.3x
P/E (forward)	24.4x
Dividend	€0.55 (1.56%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.2B
Net income (ttm): 121.5M
EPS (ttm): €1.39
P/E (trailing): 25.3x
P/E (forward): 24.4x
Market cap: 3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E24.4

P25 14.3P50 18.7P75 25.4

Trailing P/E25.3

P25 20.4P50 26.7P75 39.7

ROE4.5

P25 4.8P50 10.6P75 20.1

ROIC4.5

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/AFX indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

EUR

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-12-10
Employees	5,784
Employees change	71
Employees growth	1.24%
Enterprise value	EUR 3.6B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	1846
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	DE0005313704
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	EUR 3B
Next earnings date	2026-12-10
Price	EUR 35.32
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	vie/AFX
Website	https://www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	42.41x
Average P/E ratio (3Y)	29.24x
Average P/E ratio (5Y)	35.73x
Earnings yield	3.95%
EV/Earnings	29.67x
EV/EBIT	22.82x
EV/EBITDA	14.81x
EV/FCF	13.23x
EV/Sales	1.65x
FCF / EV yield	7.56%
FCF yield	8.97%
Forward P/E	24.42x
Graham number	27.89936
Graham upside	-21.01%
Lynch fair value	EUR 7.06
Lynch upside	-80.01%
P/B ratio	1.44x
P/E ratio	25.33x
P/FCF ratio	11.15x
P/OCF ratio	10.12x
P/S ratio	1.39x
Price / tangible book value	6.19x
Price/EBITDA ratio	13.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	7.23%
EBITDA margin	9.99%
Effective tax rate	23.25%
FCF margin	12.57%
Gross margin	51.56%
Operating margin	7.23%
Pretax margin	7.19%
Profit margin	5.57%
Profit per employee	EUR 20,957
Profitable quarters	2
Profitable years	21
Revenue per employee	EUR 376,206
ROA	2.74%
ROA (5Y)	7.01%
ROCE	5.27%
ROE	4.54%
ROE (5Y)	12.07%
ROIC	4.54%
ROIC (5Y)	10.65%
Tax / revenue	1.67%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-18.69%
EPS growth (Q)	97.46%
EPS growth (QoQ)	189.84%
EPS growth 10Y	3.84%
EPS growth 3Y	-25.96%
EPS growth 5Y	-12.01%
EPS growth quarters	1
EPS growth years	0
FCF growth	101.4%
FCF growth 3Y	38.72%
FCF growth 5Y	1.05%
Gross profit growth	-0.79%
Gross profit growth (Q)	4.38%
Gross profit growth 3Y	-2.35%
Gross profit growth 5Y	4.34%
Net income growth	-19.06%
Net income growth (Q)	93.94%
Net income growth (QoQ)	181.22%
Net income growth 3Y	-26.65%
Net income growth 5Y	-12.39%
Net income growth quarters	1
Net income growth years	0
OCF growth	53.51%
OCF growth 10Y	12.07%
OCF growth 3Y	22.96%
OCF growth 5Y	0.72%
Operating income growth	-5.35%
Operating income growth (Q)	15.87%
Operating income growth 3Y	-24.66%
Operating income growth 5Y	-14.62%
Revenue growth	0.07%
Revenue growth (Q)	2.38%
Revenue growth (QoQ)	7.39%
Revenue growth 10Y	7.18%
Revenue growth 3Y	1.6%
Revenue growth 5Y	6.86%
Revenue growth quarters	2
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -27.8M
Depreciation and amortization	EUR 60M
EBIT	EUR 157.8M
EBITDA	EUR 217.8M
EPS	EUR 1.39
Financing cash flow	EUR -181M
Free cash flow	EUR 272.5M
Gross profit	EUR 1.1B
Income taxes	EUR 36.4M
Investing cash flow	EUR -119.3M
Net borrowing	EUR -17.1M
Net cash flow	EUR -2.7M
Net income	EUR 121.5M
Operating income	EUR 157.8M
Revenue	EUR 2.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 23.98
Debt / EBITDA	2.39
Debt / equity	0.28
Debt / FCF	2.13
Interest coverage	6.47
Net cash (debt)	EUR -557.1M
Net cash / market cap	-18.33%
Net debt / EBITDA	2.56
Net debt / equity	0.26
Net debt / FCF	2.04
Piotroski F-Score	5
Shareholders' equity	EUR 2.1B
Tangible book value	EUR 490.7M
Tangible book value per share	EUR 5.61
Total cash	EUR 23.9M
Total debt	EUR 581M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.64
Current ratio	2.43
Inventory turnover	1.94
Quick ratio	1.27
Working capital	EUR 724.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.45%
Dividend growth	-8.33%
Dividend growth (3Y)	-20.63%
Dividend growth (5Y)	1.92%
Dividend growth years	0
Dividend payment date	2026-03-31
Dividend payment years	9
Dividend payout frequency	Annual
Dividend per share	EUR 0.55
Dividend yield	1.56%
Ex-dividend date	2026-03-27
Last dividend	EUR 0.55
Payout ratio	39.44%
Shareholder yield	2.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 28.89
1D price change	0.06%
1M price change	13.94%
1M total return	13.94%
1W price change	5.81%
1W total return	5.81%
1Y price change	-21.93%
1Y return CAGR	-20.18%
1Y total return	-20.17%
20-day SMA	EUR 32.89
200-day SMA	EUR 28.44
3M price change	24.37%
3M total return	24.37%
3Y price change	-53.07%
3Y return CAGR	-21.22%
3Y total return	-51.11%
50-day SMA	EUR 31.98
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 46.10
52-week high date	2025-11-26
52-week low	EUR 22.82
52-week low date	2026-03-23
5Y price change	-79.36%
5Y return CAGR	-26.26%
5Y total return	-78.19%
6M price change	33.69%
6M total return	33.69%
All-time high	EUR 200.70
All-time high date	2021-09-17
All-time low	EUR 22.82
All-time low date	2026-03-23
Average true range (ATR)	EUR 0.68
Average volume	96.9
Change from 52-week high	-23.38%
Change from 52-week low	54.78%
Change from all-time high	-82.4%
Change from all-time low	54.78%
Change from open	-0.28%
Day's gap	0.34%
High price	EUR 35.42
Low price	EUR 34.94
Monthly RSI	39.21
Open price	EUR 35.42
Position in 52-week range	79.17%
Previous close	EUR 35.30
Price vs 150-day SMA	22.26%
Price vs 20-day SMA	7.39%
Price vs 200-day SMA	24.19%
Price vs 50-day SMA	10.44%
Relative volume	1.74
RSI	69.67
Sharpe ratio	-0.39
Sharpe ratio (3Y)	-0.49
Sharpe ratio (5Y)	-0.67
Sortino ratio	-0.4
Sortino ratio (3Y)	-0.54
Sortino ratio (5Y)	-0.77
Weekly RSI	62.98
YTD price change	-11.83%
YTD total return	-9.85%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34.7M
Shares change (QoQ)	-2.98%
Shares change (YoY)	-0.45%
Shares held by institutions	15.52%

Deeper analysis on VIE/AFX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/AFX report

Is a complete VIE/AFX research report available?

No complete published report is available for vie/AFX (VIE/AFX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/AFX (VIE/AFX)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/AFX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/AFX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/AFX

Frequently asked questions